These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 22059803)

  • 1. Low HDL predicts differential blood pressure effects from two weight-loss approaches: a secondary analysis of blood pressure from a randomized, clinical weight-loss trial.
    Turer CB; Bernstein IH; Edelman DE; Yancy WS
    Diabetes Obes Metab; 2012 Apr; 14(4):375-8. PubMed ID: 22059803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
    Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
    Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of a low-carbohydrate diet vs orlistat plus a low-fat diet for weight loss.
    Yancy WS; Westman EC; McDuffie JR; Grambow SC; Jeffreys AS; Bolton J; Chalecki A; Oddone EZ
    Arch Intern Med; 2010 Jan; 170(2):136-45. PubMed ID: 20101008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonrandomized trial of weight loss with orlistat, nutrition education, diet, and exercise in obese patients with CKD: 2-year follow-up.
    MacLaughlin HL; Cook SA; Kariyawasam D; Roseke M; van Niekerk M; Macdougall IC
    Am J Kidney Dis; 2010 Jan; 55(1):69-76. PubMed ID: 19926371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term weight loss decreases the nontraditional cardiovascular risk factors interleukin-18 and matrix metalloproteinase-9 in obese subjects.
    Madsen EL; Bruun JM; Skogstrand K; Hougaard DM; Christiansen T; Richelsen B
    Metabolism; 2009 Jul; 58(7):946-53. PubMed ID: 19409578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.
    Derosa G; Cicero AF; Murdolo G; Ciccarelli L; Fogari R
    Diabetes Nutr Metab; 2004 Aug; 17(4):222-9. PubMed ID: 15575343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orlistat use in overweight women with mild hypercholesterolemia.
    Petrogiannopoulos C; Kalogeropoulos S; Latsios GS; Hartzoulakis G; Kalogeropoulos G; Zaharof A
    Int J Clin Pharmacol Res; 2002; 22(3-4):85-8. PubMed ID: 12837045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic effects of weight loss on a very-low-carbohydrate diet compared with an isocaloric high-carbohydrate diet in abdominally obese subjects.
    Tay J; Brinkworth GD; Noakes M; Keogh J; Clifton PM
    J Am Coll Cardiol; 2008 Jan; 51(1):59-67. PubMed ID: 18174038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between pretreatment dietary composition and weight loss during a randomised trial of different diet approaches.
    McVay MA; Jeffreys AS; King HA; Olsen MK; Voils CI; Yancy WS
    J Hum Nutr Diet; 2015 Feb; 28 Suppl 2():16-23. PubMed ID: 24251378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.
    Harrison SA; Fecht W; Brunt EM; Neuschwander-Tetri BA
    Hepatology; 2009 Jan; 49(1):80-6. PubMed ID: 19053049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized clinical trial of standard dietary treatment versus a low-carbohydrate/high-protein diet or the LighterLife Programme in the management of obesity*.
    Rolland C; Hession M; Murray S; Wise A; Broom I
    J Diabetes; 2009 Sep; 1(3):207-17. PubMed ID: 20923540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized study comparing the effects of a low-carbohydrate diet and a conventional diet on lipoprotein subfractions and C-reactive protein levels in patients with severe obesity.
    Seshadri P; Iqbal N; Stern L; Williams M; Chicano KL; Daily DA; McGrory J; Gracely EJ; Rader DJ; Samaha FF
    Am J Med; 2004 Sep; 117(6):398-405. PubMed ID: 15380496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of low-carbohydrate and low-fat diets on inflammation and endothelial function in diabetes.
    Davis NJ; Crandall JP; Gajavelli S; Berman JW; Tomuta N; Wylie-Rosett J; Katz SD
    J Diabetes Complications; 2011; 25(6):371-6. PubMed ID: 22036100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of weight loss with a very low carbohydrate and low fat diet on vascular function in overweight and obese patients.
    Wycherley TP; Brinkworth GD; Keogh JB; Noakes M; Buckley JD; Clifton PM
    J Intern Med; 2010 May; 267(5):452-61. PubMed ID: 20141567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of orlistat and fenofibrate, alone or in combination, on high-density lipoprotein subfractions and pre-beta1-HDL levels in obese patients with metabolic syndrome.
    Filippatos TD; Liberopoulos EN; Kostapanos M; Gazi IF; Papavasiliou EC; Kiortsis DN; Tselepis AD; Elisaf MS
    Diabetes Obes Metab; 2008 Jun; 10(6):476-83. PubMed ID: 17459096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Struggle about the best reducing diet, Fat gone by means of more fat?].
    Bischoff A
    MMW Fortschr Med; 2004 Jan; 146(1-2):4-6. PubMed ID: 18441569
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity.
    Hendricks EJ; Greenway FL; Westman EC; Gupta AK
    Obesity (Silver Spring); 2011 Dec; 19(12):2351-60. PubMed ID: 21527891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol lowering effect of dietary weight loss and orlistat treatment--efficacy and limitations.
    Erdmann J; Lippl F; Klose G; Schusdziarra V
    Aliment Pharmacol Ther; 2004 Jun; 19(11):1173-9. PubMed ID: 15153170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose orlistat effects on body weight of mildly to moderately overweight individuals: a 16 week, double-blind, placebo-controlled trial.
    Anderson JW; Schwartz SM; Hauptman J; Boldrin M; Rossi M; Bansal V; Hale CA
    Ann Pharmacother; 2006 Oct; 40(10):1717-23. PubMed ID: 16940406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a weight-loss program on mental stress-induced cardiovascular responses and recovery.
    Torres SJ; Nowson CA
    Nutrition; 2007; 23(7-8):521-8. PubMed ID: 17560080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.